Steris (STE) Research & Development (2018 - 2026)

Steris has reported Research & Development for 8 years, with the latest figure at $29.5 million in Q4 2025.

• For the quarter ending Q4 2025, Research & Development rose 7.66% year-over-year to $29.5 million; the trailing twelve-month figure through Dec 2025 stood at $111.7 million (up 3.99% YoY), and the FY2025 full-year result was $107.6 million, up 3.83% from the prior year.
• Research & Development for Q4 2025 stood at $29.5 million, up from $28.2 million in the prior quarter.
• The five-year high for Research & Development was $29.5 million in Q4 2025, with the low at $17.5 million in Q1 2021.
• Average Research & Development over 5 years is $24.9 million, with a median of $25.4 million recorded in 2022.
• Year-over-year, Research & Development surged 51.02% in 2021 and fell 6.17% in 2023.
• Tracing STE's Research & Development over 5 years: stood at $24.8 million in 2021, then gained by 2.78% to $25.5 million in 2022, then retreated by 1.02% to $25.3 million in 2023, then climbed by 8.49% to $27.4 million in 2024, then increased by 7.66% to $29.5 million in 2025.
• The last three Research & Development figures came in at $29.5 million (Q4 2025), $28.2 million (Q3 2025), and $26.4 million (Q2 2025), per Business Quant data.

Peer Comparison